Cardinal Health
J&J deals Cordis for nearly $2B | The week in medtech M&A
J&J deals Cordis to Cardinal Health for nearly $2B
CAH top suitor for JNJ’s Cordis unit | The week in medtech M&A
Report: Cardinal Health top suitor for J&J’s Cordis unit
Healthcare giant Johnson & Johnson (NYSE:JNJ) may have found a buyer for its Cordis business, according to Bloomberg News.
MRI Interventions taps Intuitive Surgical’s Grillo for CEO | Personnel Moves
Cardinal Health struggles but beats The Street in Q4
Ohio healthcare giant Cardinal Health (NYSE:CAH) got no Wall Street love after posting estimate-beating earnings today.
Sunshine Heart taps Boston Scientific R&D vet for ops role | Personnel Moves
Cardinal Health CFO Henderson to step down | Personnel Moves
Cardinal Health (NYSE:CAH) said Jeff Henderson is planning to step down at the end of fiscal 2015 after a decade as its chief financial officer.
Abbott to expand medical device footprint? | Medtech Wall Street news for the week of May 12, 2014
Cardinal Health closes $320M AccessClosure buy
Cardinal Health (NYSE:CAH) said today that it closed its $320 million all-cash acquisition of AccessClosure and its Mynx extravascular closure technology.
The Mynx biodegradable sealant products are designed to close off the femoral artery and then dissolve within 30 days.